Cargando…
Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
BACKGROUND: Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial. If antiplatelet therapy is discontinued, the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967279/ https://www.ncbi.nlm.nih.gov/pubmed/32025915 http://dx.doi.org/10.1186/s40981-018-0222-x |
_version_ | 1783488920005115904 |
---|---|
author | Takeyama, Eriko Wada, Aiko Amano, Eizo Shibuya, Hiromi |
author_facet | Takeyama, Eriko Wada, Aiko Amano, Eizo Shibuya, Hiromi |
author_sort | Takeyama, Eriko |
collection | PubMed |
description | BACKGROUND: Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial. If antiplatelet therapy is discontinued, the appropriate time to resume antiplatelet therapy is unclear. CASE PRESENTATION: A 75-year-old woman (height 134 cm, weight 37 kg) underwent flow diverter embolization for unruptured cerebral aneurysm under general anaesthesia. The patient received dual antiplatelet therapy before surgery and anticoagulation therapy intraoperatively. After surgery, the patient developed hematemesis and was diagnosed with oesophageal submucosal hematoma. Conservative treatment was initiated after discontinuing antiplatelet therapy, which was resumed 3 days after surgery. The patient showed good recovery even after the resumption of antiplatelet therapy. CONCLUSIONS: In our case, we successfully treated oesophageal submucosal hematoma developing after endovascular surgery with early resumption of postoperative antiplatelet therapy. |
format | Online Article Text |
id | pubmed-6967279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69672792020-02-04 Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report Takeyama, Eriko Wada, Aiko Amano, Eizo Shibuya, Hiromi JA Clin Rep Case Report BACKGROUND: Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial. If antiplatelet therapy is discontinued, the appropriate time to resume antiplatelet therapy is unclear. CASE PRESENTATION: A 75-year-old woman (height 134 cm, weight 37 kg) underwent flow diverter embolization for unruptured cerebral aneurysm under general anaesthesia. The patient received dual antiplatelet therapy before surgery and anticoagulation therapy intraoperatively. After surgery, the patient developed hematemesis and was diagnosed with oesophageal submucosal hematoma. Conservative treatment was initiated after discontinuing antiplatelet therapy, which was resumed 3 days after surgery. The patient showed good recovery even after the resumption of antiplatelet therapy. CONCLUSIONS: In our case, we successfully treated oesophageal submucosal hematoma developing after endovascular surgery with early resumption of postoperative antiplatelet therapy. Springer Berlin Heidelberg 2019-01-08 /pmc/articles/PMC6967279/ /pubmed/32025915 http://dx.doi.org/10.1186/s40981-018-0222-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report Takeyama, Eriko Wada, Aiko Amano, Eizo Shibuya, Hiromi Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
title | Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
title_full | Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
title_fullStr | Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
title_full_unstemmed | Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
title_short | Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
title_sort | oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967279/ https://www.ncbi.nlm.nih.gov/pubmed/32025915 http://dx.doi.org/10.1186/s40981-018-0222-x |
work_keys_str_mv | AT takeyamaeriko oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport AT wadaaiko oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport AT amanoeizo oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport AT shibuyahiromi oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport |